Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Hlavní autor: | Rahman, Tasnim |
---|---|
Další autoři: | Azam, Faruque |
Médium: | Diplomová práce |
Jazyk: | English |
Vydáno: |
Brac University
2024
|
Témata: | |
On-line přístup: | http://hdl.handle.net/10361/22174 |
Podobné jednotky
-
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Autor: Paul, Pulock
Vydáno: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Autor: Flora, Sanzida Alam
Vydáno: (2024) -
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
Autor: Hoque, Ismoth Ara
Vydáno: (2024) -
Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Autor: Karim, Samia Binte
Vydáno: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
Autor: Mim, Shanzida
Vydáno: (2023)